Nasal Splints Market Size to Reach USD 2.59 Billion by 2030, Driven by Bioabsorbable Materials and Minimally Invasive ENT Procedures
Nasal Splints Market Overview
The global nasal splints market size is estimated at USD 2.08 billion in 2025 and is projected to reach USD 2.59 billion by 2030, registering a CAGR of 4.47% during the forecast period (2025–2030). Market growth is supported by the rising number of nasal injury and sinus surgery cases, increasing adoption of minimally invasive ENT procedures, and growing demand for bioabsorbable nasal splints. Hospitals remain important purchasing centers, while ambulatory surgical centers are gaining ground as more procedures move to outpatient settings. North America holds the largest regional share, whereas Asia-Pacific is expected to record the fastest growth.
Nasal splints are used to support nasal structures, maintain alignment, and assist healing following procedures such as septoplasty, rhinoplasty, and nasal fracture repair. Their use across functional and cosmetic procedures supports demand for different product designs and materials. Manufacturers are also responding to the need for improved patient comfort, easier postoperative management, and devices suited to specific surgical requirements.
Nasal Splints Market Trends Shaping Industry Demand
Rising Prevalence of Nasal Injuries and Sinus Surgeries
The growing incidence of nasal injuries and the continued need for surgical treatment of structural and sinus-related conditions are supporting the nasal splints market. Nasal splints help maintain structural stability during recovery after procedures, making them a standard component of several ENT surgical pathways. Demand is supported by procedures addressing septal deviation, nasal fractures, and chronic sinus conditions.
As surgical volumes increase, healthcare providers require splints that provide reliable support while allowing appropriate postoperative healing. This creates opportunities for manufacturers offering products suited to different procedures and patient requirements.
Growing Adoption of Minimally Invasive ENT Procedures
Minimally invasive ENT procedures are influencing the types of nasal splints selected by surgeons and healthcare facilities. These procedures are increasingly performed in outpatient settings, where efficient treatment workflows and shorter recovery periods are important considerations.
The expansion of ambulatory surgical centers and specialty ENT clinics is creating demand for products that are convenient to use and compatible with outpatient care. Manufacturers are therefore focusing on product designs that support procedural efficiency and postoperative comfort. This trend is also encouraging wider consideration of disposable and bioabsorbable options.
Increasing Demand for Bioabsorbable Nasal Splints
Bioabsorbable polymers are gaining attention because these materials can gradually dissolve after serving their intended purpose. This can reduce the need for a separate removal procedure and address some of the discomfort associated with conventional splint removal.
Although silicone continues to account for a major portion of the market, bioabsorbable polymers are expected to record the fastest growth among material categories. Their adoption reflects growing interest in postoperative solutions that reduce additional patient visits and simplify recovery management. Manufacturers developing materials with suitable strength, stability, and predictable absorption characteristics may benefit from this demand.
Expansion of Outpatient Surgery Centers
Ambulatory surgical centers are becoming an increasingly important end-user segment as healthcare systems seek efficient alternatives to hospital-based treatment for suitable procedures. Their growth supports demand for nasal splints that can be incorporated into streamlined surgical and postoperative care pathways.
Hospitals continue to account for the largest share of the market because they handle a broad range of complex procedures and patient cases. However, the faster growth expected from ambulatory surgical centers indicates a gradual expansion of purchasing opportunities beyond traditional hospital settings.
Check out more details and stay updated with the latest industry trends: Nasal Splints Market – Mordor Intelligence
Nasal Splints Market Segmentation
The nasal splints market is segmented by product type, material, application, end user, and geography.
By Product Type
Intranasal Splints
External Nasal Splints
By Material
Silicone
Thermoplastics (ABS, PVC)
Aluminum
Bio-absorbable Polymers (PLA, PGA)
Composite and Hybrid Materials
By Application
Septoplasty
Rhinoplasty
Nasal Fracture
Sinus Surgery
Revision Surgery
By End User
Hospitals
Ambulatory Surgical Centers
Specialty ENT Clinics
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Key Players in the Nasal Splints Market
The nasal splints industry features a moderately concentrated competitive landscape, with established medical device manufacturers and specialized suppliers serving different product and material categories. Companies compete through product development, portfolio expansion, material selection, and relationships with hospitals and ENT specialists.
Key players covered in the Mordor Intelligence report include:
Medtronic plc
Stryker Corporation
Smith & Nephew plc
Boston Scientific Corporation
Olympus Corporation
Integra LifeSciences Holdings Corporation
Karl Storz SE & Co. KG
Bausch Health Companies Inc.
Meril Life Sciences Pvt Ltd
SunMed LLC
Terumo Corporation
Biomedica Deutschland GmbH
Spiggle & Theis Medizintechnik GmbH
Hood Laboratories
XION Medical
Summit Medical, LLC
KLS Martin Group
Rhinomed Ltd.
Conclusion
The nasal splints market is expected to maintain steady growth through 2030 as demand for ENT procedures, nasal injury treatment, and postoperative structural support continues. Intranasal splints and silicone remain established product and material categories, while external splints and bioabsorbable polymers offer additional growth opportunities. The expansion of ambulatory surgical centers and increasing interest in minimally invasive procedures are also influencing purchasing patterns.
North America is expected to retain its position as the largest regional market, while Asia-Pacific is projected to grow at the fastest pace. Companies that address patient comfort, material performance, and the requirements of outpatient care are positioned to participate in the market's continued development.
Comments
Post a Comment